Clopidogrel DC Granules
Direct compression clopidogrel granules that maintain chirality and content uniformity, enabling rapid scale-up of antiplatelet therapies.
Product overview
Clopidogrel is a P2Y12 antiplatelet agent used to prevent heart attack and stroke, often alongside aspirin in dual antiplatelet therapy.
Pharmaceutical granules improve the flow and compressibility of an active ingredient so that tablet presses run with consistent weight and content uniformity.
Formulation and release profile
Direct compression (DC) granules are pre-granulated so they can be blended with excipients and compressed straight into tablets, removing the wet granulation, drying and milling steps.
Pharmaceutical applications
- Tablet manufacturing by direct compression for antiplatelet products.
- Reducing in-house granulation steps and batch cycle time.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Clopidogrel DC Granules
- Form
- direct compression Granules
- Therapeutic category
- Anti-Platelet
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Clopidogrel DC Granules to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all granules Manufacturing capabilities
Other Clopidogrel products from Rraynex
- Clopidogrel + Domperidone — Granules
- Clopidogrel + Pantoprazole — Granules
- Aspirin + Clopidogrel (WW) — Pellets
- Atorvastatin + Clopidogrel — Pellets
- Clopidogrel — Pellets
- Clopidogrel (WW) — Pellets
- Clopidogrel + Aspirin — Pellets